Wu W - Search Results

1

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment.

Jin Y, Huang Y, Ren H, Huang H, Lai C, Wang W, Tong Z, Zhang H, Wu W, Liu C, Bao X, Fang W, Li H, Zhao P, Dai X. Jin Y, et al. Among authors: wu w. Biomaterials. 2024 Mar;305:122463. doi: 10.1016/j.biomaterials.2023.122463. Epub 2024 Jan 6. Biomaterials. 2024. PMID: 38232643 Review.

2

Carcinoma of Unknown Primary with EML4-ALK Fusion Response to ALK Inhibitors.

Zhao P, Peng L, Wu W, Zheng Y, Jiang W, Zhang H, Tong Z, Liu L, Ma R, Wang L, Yao M, Wang K, Fang W, Wu L. Zhao P, et al. Among authors: wu w, wu l. Oncologist. 2019 Apr;24(4):449-454. doi: 10.1634/theoncologist.2018-0439. Epub 2019 Jan 24. Oncologist. 2019. PMID: 30679319 Free PMC article.

3

Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?

Yan C, Tu XX, Wu W, Tong Z, Liu LL, Zheng Y, Jiang WQ, Zhao P, Fang WJ, Zhang HY. Yan C, et al. Among authors: wu w. World J Clin Cases. 2019 Jun 6;7(11):1253-1261. doi: 10.12998/wjcc.v7.i11.1253. World J Clin Cases. 2019. PMID: 31236389 Free PMC article. Review.

4

Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma.

Wu W, Zhou Y, Wang Y, Liu L, Lou J, Deng Y, Zhao P, Shao A. Wu W, et al. Front Oncol. 2020 Sep 3;10:1633. doi: 10.3389/fonc.2020.01633. eCollection 2020. Front Oncol. 2020. PMID: 33014821 Free PMC article. Review.

5

Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.

Bao X, Zhang H, Wu W, Cheng S, Dai X, Zhu X, Fu Q, Tong Z, Liu L, Zheng Y, Zhao P, Fang W, Liu F. Bao X, et al. Among authors: wu w. J Immunother Cancer. 2020 Oct;8(2):e001437. doi: 10.1136/jitc-2020-001437. J Immunother Cancer. 2020. PMID: 33028695 Free PMC article.

6

Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy.

Huang J, Xiao Z, An Y, Han S, Wu W, Wang Y, Guo Y, Shuai X. Huang J, et al. Among authors: wu w. Biomaterials. 2021 Feb;269:120636. doi: 10.1016/j.biomaterials.2020.120636. Epub 2021 Jan 4. Biomaterials. 2021. PMID: 33453632

7

Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy.

Guo Y, Liu Y, Wu W, Ling D, Zhang Q, Zhao P, Hu X. Guo Y, et al. Among authors: wu w. Biomaterials. 2021 Sep;276:121018. doi: 10.1016/j.biomaterials.2021.121018. Epub 2021 Jul 12. Biomaterials. 2021. PMID: 34284200 Review.

8

Recent development of gene therapy for pancreatic cancer using non-viral nanovectors.

Liu Y, Wu W, Wang Y, Han S, Yuan Y, Huang J, Shuai X, Peng Z. Liu Y, et al. Among authors: wu w. Biomater Sci. 2021 Oct 12;9(20):6673-6690. doi: 10.1039/d1bm00748c. Biomater Sci. 2021. PMID: 34378568 Review.

9

Correction: Recent development of gene therapy for pancreatic cancer using non-viral nanovectors.

Liu Y, Wu W, Wang Y, Han S, Yuan Y, Huang J, Shuai X, Zhao P. Liu Y, et al. Among authors: wu w. Biomater Sci. 2021 Oct 12;9(20):6966-6969. doi: 10.1039/d1bm90082j. Biomater Sci. 2021. PMID: 34546259

10

Case Report: Effectiveness of Targeted Treatment in a Patient With Pancreatic Cancer Harboring PALB2 Germline Mutation and KRAS Somatic Mutation.

Wu W, Liu Y, Jin Y, Liu L, Guo Y, Xu M, Hao Q, Li D, Fang W, Zhang A, Zhao P. Wu W, et al. Front Med (Lausanne). 2022 Jan 13;8:746637. doi: 10.3389/fmed.2021.746637. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35096857 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28,493 results

Search Page